SMS Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on February 06, 2015, the Board appointed an Independent Committee to explore the possibilities of Demerger of Non-FDA Manufacturing Units of the Company and submit a detailed report to the Board for consideration.
The above information is a part of company’s filings submitted to BSE.